Home
News
Create
Screeners
Insights
Godavari Drugs
82.
51
-2.87
(-3.36%)
Market Cap
₹62.14 Cr
PE Ratio
14.67
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-3.36%
1M
-15.37%
6M
-1.35%
1Y
-5.43%
5Y
+108.89%
View Company Insights
Latest news about Godavari Drugs
Godavari Drugs Limited Shareholders Approve Preferential Equity Share and Convertible Warrant Issuance at EGM
10 days ago
Godavari Drugs Limited successfully conducted its 1st EGM for FY 2025-26 on February 12, 2026, with 46 members participating via video conferencing. Shareholders overwhelmingly approved two special resolutions with 99.9998% votes in favor - one for issuing equity shares on preferential basis to promoters and non-promoters, and another for issuing convertible warrants to promoters. The meeting was chaired by Mr. Ghanshyam Jaju with full board participation, and Mrs. Vidya Harkut served as scrutinizer overseeing the electronic voting process.
Godavari Drugs Reports Q3FY26 Results, Approves ₹5.50 Crore Working Capital Loan
Feb 11, 2026
Godavari Drugs Board Approves Preferential Issue of Convertible Warrants and Equity Shares Worth ₹44.12 Crores
Jan 15, 2026
Godavari Drugs Limited Issues Clarification on Share Price Movement to BSE
Jan 08, 2026
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation